Literature DB >> 23440569

HIV seroconversion in the third trimester of pregnancy: using raltegravir to prevent mother-to-child transmission.

A Hegazi1, P Hay.   

Abstract

We describe a case of acute HIV infection in the third trimester of pregnancy associated with an extremely high viral load and the use of raltegravir to prevent HIV mother-to-child transmission.

Entities:  

Keywords:  AIDS; HIV; PMTCT; antiretroviral therapy; integrase inhibitors; pregnancy; prevention of mother-to-child transmission; raltegravir

Mesh：

Substances：

Year:  2013        PMID： 23440569     DOI： 10.1258/ijsa.2012.012121

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN： 0956-4624            Impact factor:   1.359


  3 in total

1.  Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission.

Authors:  Thanyawee Puthanakit; Nattawan Thepnarong; Surasith Chaithongwongwatthana; Suvaporn Anugulruengkitt; Orawan Anunsittichai; Tuangtip Theerawit; Sasiwimol Ubolyam; Chitsanu Pancharoen; Praphan Phanuphak
Journal:  J Virus Erad       Date:  2018-04-01

2.  A case series of third-trimester raltegravir initiation: Impact on maternal HIV-1 viral load and obstetrical outcomes.

Authors:  I Boucoiran; K Tulloch; N Pick; F Kakkar; J van Schalkwyk; D Money; M Boucher
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471

3.  A Single-Center Retrospective Cohort Analysis of Maternal and Infant Outcomes in HIV-Infected Mothers Treated with Integrase Inhibitors During Pregnancy.

Authors:  Monique L Mounce; Laura Pontiggia; Jessica L Adams
Journal:  Infect Dis Ther       Date:  2017-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.